Significant Benefits In Non-small-cell Lung Cancer From Customizing Erlotinib Treatment
Monday, September 15, 2008 - 13:35
in Health & Medicine
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, researchers report.